Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0361308 ABUSE-PROOFED DOSAGE FORM
The invention relates to a form of administration which is secured against misuse and which is thermoformed without extrusion, comprising at least one...
2016/0361307 SUBLINGUAL BUPRENORPHINE SPRAY
The invention provides sublingual formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. The invention...
2016/0361306 ABUSE-PROOFED DOSAGE FORM
A solid administration form, protected from parenteral abuse and containing at least one viscosity-increasing agent in addition to one or more active...
2016/0361305 COMPOSITIONS AND METHODS COMPRISING BUPROPION OR RELATED COMPOUNDS FOR SUSTAINED DELIVERY OF DEXTROMETHORPHAN
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically,...
2016/0361304 Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
The invention provides diamide compounds having muscarinic receptor antagonist and .beta..sub.2 adrenergic receptor agonist activity, pharmaceutical...
2016/0361303 METHOD AND COMPOSITION FOR TREATING A SEROTONIN RECEPTOR-MEDIATED CONDITION
A method and composition for treating serotonin receptor-mediated conditions.
2016/0361302 SNS-595 AND METHODS OF USING THE SAME
The present invention relates to SNS-595 and methods of treating cancer using the same.
2016/0361301 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either...
2016/0361300 USE OF TELMISARTAN TO PREVENT AND TREAT GRAFT VERSUS HOST DISEASE AND OTHER ALLOIMMUNE AND AUTOIMMUNE DISEASES
The described invention relates to methods for preventing or treating graft-versus-host disease while preserving a graft-versus-tumor effect, increasing...
2016/0361299 ANTIFUNGAL PHARMACEUTICAL COMPOSITION
Disclosed is an antifungal agent for external use, which is characterized by containing a compound represented by the general formula (1), 50 to 95 mass % of...
2016/0361298 METHODS AND COMPOSITIONS FOR TREATING CANCER
Described are compositions and methods for treating cancer. Some methods comprise the administration of an effective amount of at least one inhibitor of...
2016/0361297 Topical Compositions Comprising Fipronil and Permethrin and Methods of Use
The subject matter disclosed herein is directed to stable, highly-effective topical formulations comprising permethrin, fipronil and a solvent system that is...
2016/0361296 DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE...
The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the...
2016/0361295 FURO[3, 2-B] PYRR0L-3-ONES AS CATHESPIN S INHIBITORS
A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt, hydrate, complex or pro-drug thereof, ##STR00001## ...
2016/0361294 Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or ...
A pharmaceutical dosage form for administration twice daily, once daily or less frequently, which contains 6'-fluoro-(N-methyl- or ...
2016/0361293 NANOSTRUCTURED COMPOSITION COMPRISING INDOMETHACINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS AND...
The invention relates to a nanostructured (nanoparticular) composition comprising Indomethacine, its pharmaceutically acceptable salts and co-crystals,...
2016/0361292 Molecules That Inhibit Efflux Pumps in Multi-Drug Resistant Bacteria and Uses Thereof
Methods and compositions are provided for increasing or enhancing the efficacy of antibiotics, such as by increasing antimicrobial activity, against a variety...
2016/0361291 METHODS FOR INCREASING SKELETAL MUSCLE PROTEIN SYNTHESIS USING GREEN TEA EXTRACT
Methods of increasing skeletal muscle protein synthesis in a subject are provided. Methods of increasing or maintaining mammalian target of rapamycin (mTOR)...
2016/0361290 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASE AND/OR SYMPTOMS IN ARTHRITIS
The invention relates to the use of a combination of cannabinoids for the treatment of pain, inflammation and/or disease modification in arthritis. Preferably...
2016/0361289 TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a...
2016/0361288 PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING DIABETIC NEPHROPATHY COMPRISING THE ACTIVITY INHIBITOR...
Provided is a pharmaceutical composition for preventing or treating diabetic nephropathy, comprising a tensin like C1 domain containing phosphatase (TENC1)...
2016/0361287 COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P450
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other...
2016/0361286 4-BENZYLSULFONYL-2-BUTENENITRILE
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 4-benzylsulfonyl-2-butenenitrile, or a...
2016/0361285 METHOD FOR PURIFYING STEARIDONIC ACID
The present invention relates to a method for producing and purifying SDA at high purity and/or high yield from a raw material such as anchovy oil. According...
2016/0361284 USE OF TRANS-PALMITOLEATE IN IDENTIFYING AND TREATING METABOLIC DISEASE
The present invention provides for a novel lipokine, trans-C16:1n7-palmitoleate, which also serves as a biomarker for metabolic status. More specifically, low...
2016/0361283 Isoprenyl Compounds and Methods Thereof
Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical,...
2016/0361282 ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL...
Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by...
2016/0361281 KETOPROFEN-CONTAINING POULTICE
The invention provides a gel patch comprising a support and an adhesive layer on the support, wherein the adhesive layer comprises 1.5 to 2.5 mass % of...
2016/0361280 INKT CELL MODULATORS AND METHODS OF USING THE SAME
Disclosed herein are .alpha.-galactosylceramide (.alpha.-GalCer) analogs and compositions thereof, methods of activating invariant Natural Killer T (iNKT)...
2016/0361279 NOVEL SIGMA RECEPTOR LIGANDS AND METHODS OF MODULATING CELLULAR PROTEIN HOMEOSTASIS USING SAME
The present invention includes compounds useful in preventing, treating or ameliorating Sigma-related disorders or diseases. The compounds of the invention may...
2016/0361278 COMBINATION FORMULATION CONTAINING SUSTAINED RELEASE METFORMIN AND IMMEDIATE RELEASE HMG-COA REDUCTASE INHIBITOR
The present invention relates to a combination formulation containing metformin for treating non-insulin-dependent diabetes and an HMG-CoA reductase inhibitor...
2016/0361277 Anise Flavored Medication
An anise flavored liquid medication. The liquid medication contains phenylephrine and an anethole analog that is substantially free of aldehyde groups. In one...
2016/0361276 Pharmaceutical Combination
A combination comprising as components (a) the compound 3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol, and (b) one or more non-steroidal anti-inflammatory...
2016/0361275 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY
Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs...
2016/0361274 MODIFIED RELEASE DOSAGE FORMS OF SKELETAL MUSCLE RELAXANTS
A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an...
2016/0361273 ANTIMICROBIALS AND METHODS OF USE THEREOF FOR WOUND HEALING
This disclosure provides generally for antimicrobial compositions and methods of use comprising an anthocyanin, an anthocyanidin or metabolites thereof....
2016/0361272 EDIBLE COMPOSITION INCLUDING SAFRANAL, CROCIN, PICROCROCIN AND A VITAMIN B COMPLEX FOR TREATING THE INITIAL...
An edible composition includes safranal, crocin, picrocrocin, and a vitamin B complex including the vitamins B.sub.1, B.sub.2, B.sub.3, B.sub.6, B.sub.8,...
2016/0361271 DEVICE AND METHOD FOR THE TRANSDERMAL DELIVERY OF CANNABIDIOL
Transdermal delivery devices for the delivery of cannabidiol (CBD) are shown and described. In a reservoir-patch design, a microporous, hydrophilic membrane...
2016/0361270 UNIFORM, HIGH BASIS WEIGHT NANOFIBER FABRICS FOR MEDICAL APPLICATIONS
Described herein are devices, compositions and methods relating to the production of high basis weight, non-woven nanofiber polymer fabrics. In certain...
2016/0361269 MORPHINE CONTROLLED RELEASE SYSTEM
A composition for controlled release of an opioid from a pharmaceutical composition, the method comprises controlling the release of at least one opioid into...
2016/0361268 INTRALYMPHATIC DELIVERY OF HYALURONAN NANOPARTICLE FOR CANCER METASTASIS
Disclosed is an intralymphatic delivery method for treating lymphatic cancer using hyaluronan nanoparticles. These nanoparticles include a hyaluronic acid...
2016/0361267 NANOENCAPSULATION OF HYDROPHILIC ACTIVE COMPOUNDS
Provided is a nanoparticle including a water-soluble protein, a glucan and a hydrophilic active agent, the glucan being at least partially cross-linked by a...
2016/0361266 MODIFIED SILICA SHELL PARTICLES, AND METHODS OF MAKING AND USING THE SAME
Provided herein are silica shell particles modified on their surface with biomolecules, methods of making these particles, and methods of using these...
2016/0361265 NANOPARTICLE-MEDIATED DELIVERY OF CYTOKINES FOR MAINTENANCE OF THE REGULATORY T CELL PHENOTYPE
Compositions for delivery of growth factors needed for stable Tregs and methods of use thereof are provided. In preferred embodiments, the compositions can...
2016/0361264 DELIVERY OF PHARMACEUTICAL ACTIVE INGREDIENTS THROUGH THE SKIN AND HAIR FOLLICLES INTO DERMIS AND TRANSDERMAL...
A targeted nanosphere and submicron controlled delivery system for topical and transdermal use is disclosed. The controlled delivery system can be used as a...
2016/0361263 MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE
Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method...
2016/0361262 SUSTAINED DRUG RELEASE COMPOSITION
The invention relates to a sustained release formulation for delivering one or more pharmaceutically active agents. The formulation comprises cross-linked high...
2016/0361261 Excipient and Oral Solid Dosage Forms for Oily Drugs
The present invention is directed to an excipient which can be used to manufacture tablets containing oily active ingredients such as oily drugs, and...
2016/0361260 METHOD FOR FORMULATING LARGE DIAMETER SYNTHETIC MEMBRANE VESICLES
The present invention generally relates to the field of pharmaceutical sciences. More specifically, the present invention includes apparatus and devices for...
2016/0361259 Methods for the Preparation of Liposomes
Provided herein are methods for preparing liposomes and uses thereof. In certain embodiments, liposomes are prepared without using heat, organic solvents,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.